SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for ... - PR Newswire (press release)

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for ... PR Newswire (press release) Rheumatoid arthritis is a chronic and debilitating disease that affects more than three million people in Europe. Signs and symptoms of RA include pain, ... and more »

GlaxoSmithKline Signs Research Deal With Chroma Therapeutics - Wall Street Journal

stv.tv

GlaxoSmithKline Signs Research Deal With Chroma Therapeutics Wall Street Journal LN) said Tuesday it signed a deal worth up to billion with Chroma Therapeutics Ltd. to develop new drugs for rheumatoid arthritis. ... Glaxo signs drug-development deal with British firmPhiladelphia Inquirer GSK signs arthritis drug development collaborationPharmafocus Glaxo signs potential bln drug deal with ChromaReuters Independent -AltAssets -Genetic Engineering News (press release) all 45 news articles »

Roche Files Mabthera In Rheumatoid Arthritis In Europe - EasyBourse.com

Roche Files Mabthera In Rheumatoid Arthritis In Europe EasyBourse.com VX) said Friday it has submiited Mabthera to the European health authority for extended use in patients suffering rheumatoid arthritis. ... and more »

Arthritis Diagnosis Can Change - KFSM

Arthritis Diagnosis Can Change KFSM Symptoms of MCTD may begin with arthritis. So, doctors may correctly diagnose rheumatoid arthritis in a person with joint pain and swelling in multiple ... and more »